Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients
May 22, 2007
Journal of Viral Hepatitis Jun 2007 Vol.14 N.6 p.387–391
B. Ramos11Department of Infectious Diseases, Hospital Carlos III, Madrid, M. Núñez11Department of Infectious Diseases, Hospital Carlos III, Madrid, A. Rendón11Department of Infectious Diseases, Hospital Carlos III, Madrid, M. A. Berdún22Hospital San Jorge, Huesca, E. Losada33Hospital Universitario, Santiago de Compostela, I. Santos44Hospital La Princesa, Madrid, S. Echevarría55Hospital Marqués de Valdecilla, Santander, A. Ocampo66Hospital Xeral Cíes, Vigo, C. Miralles66Hospital Xeral Cíes, Vigo, P. Arazo77Hospital Miguel Servet, Zaragoza, P. Barreiro11Department of Infectious Diseases, Hospital Carlos III, Madrid, M. Romero88Hospital de Sant Pau, Barcelona, P. Labarga11Department of Infectious Diseases, Hospital Carlos III, Madrid, J. M. Guardiola88Hospital de Sant Pau, Barcelona, J. Garcia-Samaniego99Hepatology Unit, Hospital Carlos III, Madrid, Spain and V. Soriano11Department of Infectious Diseases, Hospital Carlos III, Madrid1Department of Infectious Diseases, Hospital Carlos III, Madrid; 2Hospital San Jorge, Huesca; 3Hospital Universitario, Santiago de Compostela; 4Hospital La Princesa, Madrid; 5Hospital Marqués de Valdecilla, Santander; 6Hospital Xeral Cíes, Vigo; 7Hospital Miguel Servet, Zaragoza; 8Hospital de Sant Pau, Barcelona; and 9Hepatology Unit, Hospital Carlos III, Madrid, Spain
abstract
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2006.00806.x
Entry Filed under: Antivirales no HIV, HIV/SIDA Co-infeccion HCV. .
Trackback this post | Subscribe to the comments via RSS Feed